Carsten Boess

Carsten Boess has an estimated net worth of $21.6 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Kiniksa Pharmaceuticals, Ltd., Health Sciences Acquisitions Corp 2, ROCKET PHARMACEUTICALS, INC., Avidity Biosciences, Inc., ALEXION PHARMACEUTICALS INC, SYNAGEVA BIOPHARMA CORP, and Atrium Therapeutics, Inc..

2011 was Carsten Boess's most active year for acquiring shares with 13 total transactions. Carsten Boess's most active month to acquire stocks was the month of May. 2007 was Carsten Boess's most active year for disposing of shares, totalling 77 transactions. Carsten Boess's most active month to dispose stocks was the month of November. 2015 saw Carsten Boess paying a total of $1,206,485.38 for 66,297 shares, this is the most they've acquired in one year. In 2014 Carsten Boess cashed out on 90,516 shares for a total of $3,860,609.58, their largest year based on trade value.